---
schema_version: "secwatch.filing_event.v1"
accession: "0000097745-26-000173"
form_type: "8-K"
ticker: "TMO"
cik: "0000097745"
company_name: "THERMO FISHER SCIENTIFIC INC."
filed_at: "2026-10-21T10:03:16+00:00"
generated_at: "2026-10-21T10:05:04.641503+00:00"
event_type: "earnings"
sentiment: "positive"
materiality_score: 0.78
calibrated_materiality_score: 0.78
confidence: "high"
source: SEC EDGAR
---

# Thermo Fisher Q3 2026 revenue up 9% to $12.14B; adjusted EPS $6.68, up 15%

## Summary
- Revenue $12.14B vs $11.12B a year ago, +9% reported with 6% organic growth.
- GAAP diluted EPS $4.64 (+9%); adjusted EPS $6.68 (+15%).
- GAAP operating income $2.26B (+17%), margin 18.6% vs 17.4%; adjusted operating income $2.97B (+15%), margin 24.5% vs 23.3%.
- Completed previously announced divestiture of the microbiology business during the quarter.
- Launched Orbitrap Isora mass spectrometer, EMPAD G2 detector, FDA-cleared EliA CTD 13 Screen and Ion 560 chip; updated 2026 guidance to come on the 7:00 a.m. ET call.

## SEC filing metadata
- accession: 0000097745-26-000173
- form_type: 8-K
- ticker: TMO
- cik: 0000097745
- company_name: THERMO FISHER SCIENTIFIC INC.
- filed_at: 2026-10-21T10:03:16+00:00
- event_type: earnings
- sentiment: positive
- materiality_score: 0.78
- calibrated_materiality_score: 0.78
- confidence: high
- sec_items: 2.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/97745/000009774526000173/0000097745-26-000173-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/97745/000009774526000173/tmo-20261021.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0000097745-26-000173
- JSON: https://secwatch.observer/filing/0000097745-26-000173.json
- Plain text: https://secwatch.observer/filing/0000097745-26-000173.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.